EHI
AZN icon

Eagle Health Investments’s AstraZeneca AZN Stock Holding History

Eagle Health Investments’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-188,983
Closed -$20.7M – 28
2022
Q3 		$20.7M Sell
188,983
-2,550
-1% -$323K 4.76% 12
2022
Q2 		$25.3M Sell
191,533
-31,300
-14% -$4.11M 5.9% 5
2022
Q1 		$29.6M Sell
222,833
-83,000
-27% -$9.95M 7.28% 3
2021
Q4 		$35.6M Buy
305,833
+81,050
+36% +$9.54M 8.68% 2
2021
Q3 		$27M Buy
224,783
+24,888
+12% +$2.9M 8.56% 1
2021
Q2 		$23.9M Buy
199,895
+21,500
+12% +$2.36M 8.22% 1
2021
Q1 		$17.7M Buy
178,395
+63,345
+55% +$6.37M 7.2% 5
2020
Q4 		$11.5M Buy
+115,050
New +$12.2M 7.36% 5

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return